Victoria Isiev
Nurse Practitioner · Santa Clarita, CANPI 1306628623
Payments from drug & device makers
Across 156 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$679
- AstraZeneca$635
- Novo Nordisk$429
- GSK$299
- Otsuka America Pharmaceutical, Inc.$271
- Phathom Pharmaceuticals, Inc.$241
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,938100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 16 | $679 |
| AstraZeneca | 25 | $635 |
| Novo Nordisk | 26 | $429 |
| GSK | 15 | $299 |
| Otsuka America Pharmaceutical, Inc. | 14 | $271 |
| Phathom Pharmaceuticals, Inc. | 9 | $241 |
| Regeneron Healthcare Solutions, Inc. | 4 | $212 |
| Amgen | 8 | $187 |
| Pfizer | 7 | $182 |
| Dexcom, Inc. | 5 | $177 |
| Shield Therapeutics Inc | 5 | $105 |
| Sage Therapeutics, LLC | 3 | $81 |
| Boehringer Ingelheim | 3 | $69 |
| Novartis | 2 | $66 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
| Gilead | 2 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Phadia US Inc. | 2 | $39 |
| Vertex | 1 | $28 |
| Mylan Specialty L.p. | 1 | $26 |
| Exact Sciences | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,938 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 76 | $108,152 |
| JardianceEmpagliflozin | 37 | $46,600 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 51 | $40,105 |
| MounjaroTirzepatide | 24 | $30,922 |
| ProliaDenosumab | 15 | $25,003 |
| EliquisApixaban | 30 | $23,928 |
| TrulicityDulaglutide | 24 | $23,903 |
| JanumetSitagliptin Phos/Metformin Hcl | 14 | $14,774 |
| JanuviaSitagliptin Phosphate | 11 | $14,700 |
| FarxigaDapagliflozin Propanediol | 20 | $11,226 |
| LinzessLinaclotide | 11 | $8,879 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $8,542 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 168 | $5,526 |
| Atorvastatin Calcium | 230 | $1,693 |
| Levothyroxine Sodium | 102 | $1,336 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $429 | $108,15276 claims |
| Lilly USA, LLCMounjaro, Trulicity | $679 | $54,82548 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $299 | $48,64773 claims |
| Boehringer IngelheimJardiance | $69 | $46,60037 claims |
| AmgenProlia | $187 | $25,00315 claims |
| PfizerEliquis | $182 | $23,92830 claims |
| AstraZenecaFarxiga | $635 | $11,22620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in Santa Clarita
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.